Cardiovascular disease in patients with non-alcoholic fatty liver disease

Annals of Gastroenterology

Volumn 25, Issue 3, 2012, Pages 276-277

  Kantartzis, Konstantinos ^a   Stefan, Norbert ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; FETUIN A; GLUCOSE; LIPID;

AGE DISTRIBUTION; ALCOHOLIC FATTY LIVER; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; ECHOGRAPHY; FOLLOW UP; HUMAN; HYPERCOAGULABILITY; HYPERGLYCEMIA; HYPERTENSION; INSULIN RESISTANCE; LIPID BLOOD LEVEL; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; PROTEIN SECRETION; RISK FACTOR;

EID: 84863541423     PISSN: 11087471     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Wong VW, Wong GL, Yip GW, et al. Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut 2011;60:1721-1727.
2. Kantartzis K, Machann J, Schick F, et al. The impact of liver fat vs visceral fat in determining categories of prediabetes. Diabetologia 2010;53:882-889.
3. Speliotes EK, Massaro JM, Hoffmann U, et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology 2010;51:1979-1987.
4. Fisher E, Stefan N, Saar K, et al. Association of AHSG Gene Polymorphisms with Fetuin-A Plasma Levels and Cardiovascular Diseases in the EPIC-Potsdam Study. Circ Cardiovasc Genet 2009;2:607-613.
5. Stefan N, Hennige AM, Staiger H, et al. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 2006;29:853-857.
6. Ix JH, Wassel CL, Kanaya AM, et al. Fetuin-A and incident diabetes mellitus in older persons. JAMA 2008;300:182-188.
7. Weikert C, Stefan N, Schulze MB, et al. Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 2008;118:2555-2562.
8. Blüher M, Tönjes A, Stumvoll M. Does retinol-binding protein 4 cause or reflect fatty liver disease? Hepatology 2008;48:4-6.
9. Peter A, Kantartzis K, Machann J, et al. Relationships of circulating sex hormone-binding globulin with metabolic traits in humans. Diabetes 2010;59:3167-3173.
10. Targher G, Day C P, Bonora E. Risk of cardiovascular Disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010;363:1341-1350.
11. Lazo M, Hernaez R, Bonekamp S, et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 2011;343:d6891.
12. Stefan N, Häring HU. The metabolically benign and malignant fatty liver. Diabetes 2011;60:2011-2017.